IMMX

Immix Biopharma, Inc.

Price Chart

No historical data available

Latest Quote

$13.80

-0.23 (-1.64%)

Current Price

Previous Close	$14.03
Open	$13.86
Day High	$14.24
Day Low	$13.62
Volume	53,437

Fetched: 2026-09-01T13:38:39

Stock Information

Shares Outstanding	71.19M
Total Debt	$1.00M
Cash Equivalents	$232.11M
Net Income	$-39.92M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$982.42M
EPS (TTM)	$-0.88
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Immix Biopharma, Inc.

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

📰 Latest News

No news articles available at the moment. Check back later for updates on IMMX.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$29,956,415	$22,674,680	$16,141,113	$8,218,948
Net Non Operating Interest Income Expense	$555,526	$1,017,354	$572,006	$-497
Operating Expense	$29,956,415	$22,674,680	$16,141,113	$8,218,948
General And Administrative Expense	$13,697,817	$11,381,978	$7,406,082	$4,023,170
Interest Expense	-	-	$0	$497
Interest Expense Non Operating	-	-	$0	$497
Other Income Expense	-	-	-	-
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Net Interest Income	$555,526	$1,017,354	$572,006	$-497
Interest Income	$555,526	$1,017,354	$572,006	$0
Normalized Income	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Net Income From Continuing And Discontinued Operation	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Total Operating Income As Reported	$-29,956,415	$-22,674,680	$-16,141,113	$-8,218,948
Net Income Common Stockholders	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Net Income	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Net Income Including Noncontrolling Interests	$-29,438,613	$-21,698,363	$-15,595,522	$-8,229,713
Net Income Continuous Operations	$-29,438,613	$-21,698,363	$-15,595,522	$-8,229,713
Pretax Income	$-29,400,889	$-21,657,326	$-15,569,107	$-8,219,445
Interest Income Non Operating	$555,526	$1,017,354	$572,006	$0
Operating Income	$-29,956,415	$-22,674,680	$-16,141,113	$-8,218,948
Special Income Charges	-	-	-	$0
Per Share
Diluted EPS	$-0.89	$-0.76	$-0.89	$-0.59
Basic EPS	$-0.89	$-0.76	$-0.89	$-0.59
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-29,591,914	$-22,559,292	$-16,135,645	$-8,216,813
Reconciled Depreciation	$364,501	$115,388	$5,468	$2,135
EBITDA (Bullshit earnings)	$-29,591,914	$-22,559,292	$-16,135,645	$-8,216,813
EBIT	$-29,956,415	$-22,674,680	$-16,141,113	$-8,218,948
Diluted Average Shares	$32,965,706	$28,285,637	$17,341,146	$13,887,309
Basic Average Shares	$32,965,706	$28,285,637	$17,341,146	$13,887,309
Diluted NI Availto Com Stockholders	$-29,438,613	$-21,613,376	$-15,426,048	$-8,229,713
Minority Interests	$0	$84,987	$169,474	$0
Tax Provision	$37,724	$41,037	$26,415	$10,268
Research And Development	$16,258,598	$11,292,702	$8,735,031	$4,195,778
Selling General And Administration	$13,697,817	$11,381,978	$7,406,082	$4,023,170
Other Gand A	$13,697,817	$11,381,978	$7,406,082	$4,023,170
Total Unusual Items	-	-	-	$0
Total Unusual Items Excluding Goodwill	-	-	-	$0
Other Special Charges	-	-	-	-
Gain On Sale Of Security	-	-	-	-

Fetched: 2026-08-24

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Total Assets	$104,840,341	$22,947,872	$19,925,160	$14,908,101
Total Non Current Assets	$3,602,586	$2,750,038	$137,410	$10,284
Other Non Current Assets	$20,418	$20,418	-	$6,724
Non Current Deferred Assets	$93,630	$0	$87,229	$6,724
Current Assets	$101,237,755	$20,197,834	$19,787,750	$14,897,817
Other Current Assets	$150,721	$32,271	$44,582	$78,067
Prepaid Assets	$677,608	$509,239	$1,061,194	$1,127,331
Receivables	$0	$1,974,370	$1,172,183	$255,705
Taxes Receivable	$0	$1,974,370	$1,172,183	$255,705
Cash Cash Equivalents And Short Term Investments	$100,409,426	$17,681,954	$17,509,791	$13,436,714
Cash And Cash Equivalents	$93,928,566	$17,681,954	$17,509,791	$13,436,714
Cash Financial	-	-	$17,509,791	$13,436,714
Debt
Total Debt	$1,072,964	$1,074,770	$0	-
Long Term Debt And Capital Lease Obligation	$933,625	$1,009,551	$0	-
Current Debt And Capital Lease Obligation	$139,339	$65,219	-	-
Current Debt	-	-	-	-
Liabilities
Total Liabilities Net Minority Interest	$11,044,171	$9,696,669	$3,721,783	$1,748,296
Total Non Current Liabilities Net Minority Interest	$933,625	$1,009,551	$0	$475,000
Current Liabilities	$10,110,546	$8,687,118	$3,721,783	$1,273,296
Payables And Accrued Expenses	$9,029,044	$7,963,738	$3,143,929	$1,273,296
Payables	$5,442,737	$5,388,494	$1,433,022	$143,074
Accounts Payable	$5,442,737	$5,388,494	$1,433,022	$143,074
Current Notes Payable	-	-	-	$0
Interest Payable	-	-	-	$0
Equity
Common Stock Equity	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Total Equity Gross Minority Interest	$93,796,170	$13,251,203	$16,203,377	$13,159,805
Stockholders Equity	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Gains Losses Not Affecting Retained Earnings	$60,160	$-1,056	$134,666	$87,021
Other Equity Adjustments	$60,160	$-1,056	$134,666	$87,021
Retained Earnings	$-104,463,284	$-75,024,671	$-53,411,295	$-37,985,247
Other
Treasury Shares Number	$72,363	$72,363	$72,363	$72,363
Ordinary Shares Number	$52,951,103	$27,540,020	$19,922,356	$13,892,122
Share Issued	$53,023,466	$27,612,383	$19,994,719	$13,964,485
Tangible Book Value	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Invested Capital	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Working Capital	$91,127,209	$11,510,716	$16,065,967	$13,624,521
Capital Lease Obligations	$1,072,964	$1,074,770	$0	-
Total Capitalization	$93,796,170	$13,251,203	$16,405,114	$13,159,805
Minority Interest	$0	$0	$-201,737	$0
Treasury Stock	$99,963	$99,963	$99,963	$99,963
Additional Paid In Capital	$198,293,956	$88,374,131	$69,779,706	$51,156,597
Capital Stock	$5,301	$2,762	$2,000	$1,397
Common Stock	$5,301	$2,762	$2,000	$1,397
Long Term Capital Lease Obligation	$933,625	$1,009,551	$0	-
Current Capital Lease Obligation	$139,339	$65,219	$0	-
Pensionand Other Post Retirement Benefit Plans Current	$942,163	$658,161	$577,854	-
Current Accrued Expenses	$3,586,307	$2,575,244	$1,710,907	$1,130,222
Net PPE	$3,488,538	$2,729,620	$50,181	$3,560
Accumulated Depreciation	$-293,001	$-47,255	$-14,314	-
Gross PPE	$3,781,539	$2,776,875	$64,495	$3,560
Leases	$1,244,741	$0	-	-
Construction In Progress	$0	$938,768	$0	-
Other Properties	$1,565,985	$844,740	$60,599	$3,560
Machinery Furniture Equipment	$3,896	$3,896	$3,896	-
Buildings And Improvements	$966,917	$989,471	$0	-
Properties	$0	$0	$0	-
Other Short Term Investments	$6,480,860	$0	-	-
Preferred Stock	-	$0	$0	$0
Long Term Provisions	-	-	-	$475,000

Fetched: 2026-08-24

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-24,663,229	$-15,772,782	$-11,423,527	$-7,408,303
Operating Activities
Operating Cash Flow	$-23,930,304	$-14,595,102	$-11,371,438	$-7,408,303
Cash Flow From Continuing Operating Activities	$-23,930,304	$-14,595,102	$-11,371,438	$-7,408,303
Operating Gains Losses	-	-	-	-
Investing Activities
Capital Expenditure	$-732,925	$-1,177,680	$-52,089	-
Investing Cash Flow	$-7,213,785	$-1,177,680	$-52,089	$0
Cash Flow From Continuing Investing Activities	$-7,213,785	$-1,177,680	$-52,089	$0
Financing Activities
Issuance Of Capital Stock	$107,392,716	$15,946,078	$15,695,510	$3,388,750
Financing Cash Flow	$107,386,859	$15,948,567	$15,463,512	$3,232,063
Cash Flow From Continuing Financing Activities	$107,386,859	$15,948,567	$15,463,512	$3,232,063
Net Other Financing Charges	$-136,999	-	$-234,616	$-6,724
Net Common Stock Issuance	$107,392,716	$15,946,078	$15,695,510	$3,288,787
Common Stock Issuance	$107,392,716	$15,946,078	$15,695,510	$3,388,750
Repurchase Of Capital Stock	-	-	$0	$-99,963
Other
Interest Paid Supplemental Data	$0	$0	$0	$9,596
Income Tax Paid Supplemental Data	$0	$0	$0	$0
End Cash Position	$93,928,566	$17,681,954	$17,509,791	$13,436,714
Beginning Cash Position	$17,681,954	$17,509,791	$13,436,714	$17,644,478
Effect Of Exchange Rate Changes	$3,842	$-3,622	$33,092	$-31,524
Changes In Cash	$76,242,770	$175,785	$4,039,985	$-4,176,240
Proceeds From Stock Option Exercised	$131,142	$2,489	$2,618	$0
Net Investment Purchase And Sale	$-6,480,860	$0	-	-
Purchase Of Investment	$-6,480,860	$0	-	-
Net PPE Purchase And Sale	$-732,925	$-1,177,680	$-52,089	$0
Purchase Of PPE	$-732,925	$-1,177,680	$-52,089	$0
Change In Working Capital	$2,701,933	$3,967,300	$1,652,908	$195,206
Change In Other Current Liabilities	$-98,006	$2,852	$0	-
Change In Other Current Assets	$0	$-20,418	$0	-
Change In Payables And Accrued Expense	$1,027,161	$4,401,623	$2,434,467	$1,122,637
Change In Payable	$1,027,161	$4,401,623	$2,434,467	$1,131,736
Change In Account Payable	$1,027,161	$4,401,623	$2,434,467	$1,131,736
Change In Prepaid Assets	$-286,729	$554,770	$111,842	$-691,047
Change In Receivables	$2,059,507	$-971,527	$-893,401	$-236,384
Stock Based Compensation	$2,441,875	$3,020,573	$2,565,708	$624,069
Depreciation Amortization Depletion	$364,501	$115,388	$5,468	$2,135
Depreciation And Amortization	$364,501	$115,388	$5,468	$2,135
Depreciation	$364,501	$115,388	$5,468	$2,135
Net Income From Continuing Operations	$-29,438,613	$-21,698,363	$-15,595,522	$-8,229,713
Repayment Of Debt	-	-	$0	$-50,000
Common Stock Payments	-	-	$0	$-99,963
Net Issuance Payments Of Debt	-	-	$0	$-50,000
Net Short Term Debt Issuance	-	-	$0	$-50,000
Short Term Debt Payments	-	-	$0	$-50,000
Change In Accrued Expense	-	-	$0	$-9,099
Change In Interest Payable	-	-	$0	$-9,099
Issuance Of Debt	-	-	-	$0
Short Term Debt Issuance	-	-	-	$0
Other Non Cash Items	-	-	-	$100,000
Net Long Term Debt Issuance	-	-	-	-
Long Term Debt Issuance	-	-	-	-
Gain Loss On Investment Securities	-	-	-	-

Fetched: 2026-08-24